Emtex Life Science Celebrates Two New Publications with Neopharm Bulgaria Ltd.

Emtex Life Science Celebrates Two New Publications with Neopharm Bulgaria Ltd.

Emtex Life Science is very proud to have contributed to 2 successful publications about the efficacy and safety of products developed by Neopharm Bulgaria Ltd.

 

Both publications describe results from a Phase 4, placebo-controlled clinical trial.

 

One is about a high-dose, multistrain probiotic mix (Sinquanon®), specially designed for prevention of antibiotic-associated diarrhea in adults: https://academic.oup.com/ofid/article/11/11/ofae615/7828570.

 

The other is about a food supplement (Atusin® CAP) combining 4 types of purified essential oils, bromelain, and green Brazilian propolis, specially designed to treat acute uncomplicated bronchitis in adults: https://bmcpulmmed.biomedcentral.com/articles/10.1186/s12890-025-03912-6.

 

Are you also ready for a fruitful collaboration with our medical writing team?

Find out more about our writing services, including manuscripts, graphical abstracts, responses to letters to the editor, and many more, here: https://www.emtexlifescience.com/services#media-communications.

Customer testimonial:

 
“I wanted to express my gratitude to you and the entire Emtex team for your great support and partnership. I know it has been a demanding year on so many levels but the professionalism and quality of work from Emtex never wavered”

Global Head Regulatory Medical Writing